Qiuyu Zhang

Fuzhou, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

ASO Visual Abstract: Distal Resection Margin Collagen Score to Predict Major Low Anterior Resection Syndrome After Neoadjuvant Chemoradiotherapy in Rectal Cancer.

ASO Visual Abstract: Distal Resection Margin Collagen Score to Predict Major Low Anterior Resection Syndrome After Neoadjuvant Chemoradiotherapy in Rectal Cancer.

Journal: Annals of surgical oncology

Published: August 12, 2026

Distal Resection Margin Collagen Score to Predict Major Low Anterior Resection Syndrome After Neoadjuvant Chemoradiotherapy in Rectal Cancer.

Distal Resection Margin Collagen Score to Predict Major Low Anterior Resection Syndrome After Neoadjuvant Chemoradiotherapy in Rectal Cancer.

Journal: Annals of surgical oncology

Published: March 09, 2026

Glycolipid metabolism reprogramming and transcriptional splicing of ARID4B genes during the response to summer seawater warming in Patinopecten yessoensis.

Glycolipid metabolism reprogramming and transcriptional splicing of ARID4B genes during the response to summer seawater warming in Patinopecten yessoensis.

Journal: Marine pollution bulletin

Published: February 14, 2026

Chinese Expert Consensus on Leptomeningeal Metastases of Lung Cancer.

Chinese Expert Consensus on Leptomeningeal Metastases of Lung Cancer.

Journal: Thoracic cancer

Published: April 19, 2025

Pretreatment pulmonary tumor necrosis is a promising prognostic imaging biomarker for first-line anti-PD-1/PD-L1 therapy in advanced lung squamous cell carcinoma: a multi-institutional, propensity score-matching cohort analysis.

Pretreatment pulmonary tumor necrosis is a promising prognostic imaging biomarker for first-line anti-PD-1/PD-L1 therapy in advanced lung squamous cell carcinoma: a multi-institutional, propensity score-matching cohort analysis.

Journal: Therapeutic advances in medical oncology

Published: December 12, 2023

Rechallenge of immune checkpoint inhibitors in advanced non-small cell lung cancer.

Rechallenge of immune checkpoint inhibitors in advanced non-small cell lung cancer.

Journal: Thoracic cancer

Published: November 27, 2023

Clinical definition of secondary resistance to immunotherapy in non-small cell lung cancer.

Clinical definition of secondary resistance to immunotherapy in non-small cell lung cancer.

Journal: Thoracic cancer

Published: October 25, 2023

Cerebrospinal fluid circulating tumor DNA contributes to the detection and characterization of leptomeningeal metastasis in non-small cell lung cancer.

Cerebrospinal fluid circulating tumor DNA contributes to the detection and characterization of leptomeningeal metastasis in non-small cell lung cancer.

Journal: Journal of neuro-oncology

Published: October 19, 2023

Baseline C-reactive protein predicts efficacy of the first-line immune checkpoint inhibitors plus chemotherapy in advanced lung squamous cell carcinoma: a retrospective, multicenter study.

Baseline C-reactive protein predicts efficacy of the first-line immune checkpoint inhibitors plus chemotherapy in advanced lung squamous cell carcinoma: a retrospective, multicenter study.

Journal: BMC cancer

Published: October 02, 2023

A novel approach to evaluation of tumor response for advanced pulmonary adenocarcinoma using the intertumoral heterogeneity response score.

A novel approach to evaluation of tumor response for advanced pulmonary adenocarcinoma using the intertumoral heterogeneity response score.

Journal: MedComm

Published: July 19, 2023

Dynamic change in Siglec-15 expression in peritumoral macrophages confers an immunosuppressive microenvironment and poor outcome in glioma.

Dynamic change in Siglec-15 expression in peritumoral macrophages confers an immunosuppressive microenvironment and poor outcome in glioma.

Journal: Frontiers in immunology

Published: February 05, 2023

Interaction of glioma-associated microglia/macrophages and anti-PD1 immunotherapy.

Interaction of glioma-associated microglia/macrophages and anti-PD1 immunotherapy.

Journal: Cancer immunology, immunotherapy : CII

Published: October 25, 2022

Showing 1-12 of 17

Last Updated: 09/26/2026